A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination
- Status
- COMPLETED
- Phase
- NA
Handheld Ultrasound (HHUS) for Home Use in Hemophilia
- Status
- COMPLETED
- Phase
- N/A
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
- Status
- RECRUITING
- Phase
- N/A
Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)
- Status
- COMPLETED
- Phase
- N/A
Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)
- Status
- COMPLETED
- Phase
- PHASE4
The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
- Status
- UNKNOWN
- Phase
- PHASE3
Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
- Status
- UNKNOWN
- Phase
- PHASE1
Emicizumab PUPs and Nuwiq ITI Study
- Status
- WITHDRAWN
- Phase
- PHASE3
Treatment of Hemophilia A Patients With FVIII Inhibitors
- Status
- RECRUITING
- Phase
- N/A
Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.
- Status
- UNKNOWN
- Phase
- PHASE4
Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.
- Status
- UNKNOWN
- Phase
- PHASE3
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Optimizing the Use of Prophylaxis in Patients With Severe Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE4